Why bullish investors have it all wrong heading into 2025, according to the biggest bear among Wall Street banks
With valuations as high as they are, there may be little room for error in the year ahead.
Who is right about ‘Maganomics’: bearish economists or bullish investors?
Earnings for the Magnificent 7 are forecast to grow 21 per cent this year, down from 33 per cent in 2024. That is still ahead ...
The Financial Times13d
Who is right about ‘Maganomics’: bearish economists or bullish investors?
Barry Bannister, chief equity strategist at Stifel, said: “Immigration will initially target border control and criminal elements, but with many new immigrants actually tilting Republican . . .
AOL21d
Here's where Wall Street sees stocks heading after the best 2-year stretch since '97-'98
Stifel chief investment strategist Barry Bannister sees sticky inflation prompting the Federal Reserve to hold interest rates high as economic growth weakens. These factors may serve as key ...
Fed official delivers a blunt message to the stock market, which ignores it
Federal Reserve Governor Lisa Cook on Monday gave one of the bluntest warnings an official at the central bank has ever delivered about the stock market.
Benzinga.com13d
What Analysts Are Saying About Stifel Financial Stock
In the latest quarter, 5 analysts provided ratings for Stifel Financial SF, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by ...
Bloomberg L.P.7d
Canada’s Eight Capital to Shut Down as Stifel Swoops In for Bankers
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...
Business Insider9d
Stifel Nicolaus Remains a Buy on X4 Pharmaceuticals (XFOR)
In a report released yesterday, Stephen Willey from Stifel Nicolaus maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report). The company’s shares closed yesterday at $0.57.